N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide

C28H40N2O8S — CID 58362796

IUPACN-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide
SMILESCC1(C)O[C@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@]2(C(=O)CNS(=O)(=O)N2CCOCC2)O1
InChIInChI=1S/C28H40N2O8S/c1-25(2)37-23-14-20-19-6-5-17-13-18(31)7-8-26(17,3)24(19)21(32)15-27(20,4)28(23,38-25)22(33)16-29-39(34,35)30-9-11-36-12-10-30/h7-8,13,19-21,23-24,29,32H,5-6,9-12,14-16H2,1-4H3/t19?,20?,21?,23-,24?,26?,27?,28+/m0/s1
InChIKeyKTWQGIUSRJXTDG-RVPNPJSESA-N
MW564.70 g/mol
LogP1.50
Rot. Bonds5

About N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide

N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide (PubChem CID 58362796) has the molecular formula C28H40N2O8S and a molecular weight of 564.70 g/mol. Its IUPAC name is N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide.

Molecular Properties

Compound NameN-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide
PubChem CID58362796
Molecular FormulaC28H40N2O8S
Molecular Weight564.70 g/mol
Exact Mass564.25
IUPAC NameN-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide
SMILESCC1(C)O[C@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@]2(C(=O)CNS(=O)(=O)N2CCOCC2)O1
InChIInChI=1S/C28H40N2O8S/c1-25(2)37-23-14-20-19-6-5-17-13-18(31)7-8-26(17,3)24(19)21(32)15-27(20,4)28(23,38-25)22(33)16-29-39(34,35)30-9-11-36-12-10-30/h7-8,13,19-21,23-24,29,32H,5-6,9-12,14-16H2,1-4H3/t19?,20?,21?,23-,24?,26?,27?,28+/m0/s1
InChIKeyKTWQGIUSRJXTDG-RVPNPJSESA-N
XLogP1.50
TPSA131.47 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500564.70
LogP ≤ 51.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide?
The IUPAC name of N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide (CID 58362796) is N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide.
What is the SMILES notation for N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide?
The canonical SMILES for N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide is CC1(C)O[C@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@]2(C(=O)CNS(=O)(=O)N2CCOCC2)O1.
What is the InChIKey of N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide?
The InChIKey is KTWQGIUSRJXTDG-RVPNPJSESA-N. The full InChI is InChI=1S/C28H40N2O8S/c1-25(2)37-23-14-20-19-6-5-17-13-18(31)7-8-26(17,3)24(19)21(32)15-27(20,4)28(23,38-25)22(33)16-29-39(34,35)30-9-11-36-12-10-30/h7-8,13,19-21,23-24,29,32H,5-6,9-12,14-16H2,1-4H3/t19?,20?,21?,23-,24?,26?,27?,28+/m0/s1.
What are the key properties of N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide?
N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide has a molecular weight of 564.70 g/mol, XLogP of 1.50, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(4S,8S,11S)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl]morpholine-4-sulfonamide is sourced from PubChem (CID 58362796), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).